SignatureFD’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-213
Closed -$2.94K 3278
2023
Q2
$2.94K Buy
213
+198
+1,320% +$2.97K ﹤0.01% 2683
2023
Q1
$244 Hold
15
﹤0.01% 3170
2022
Q4
$266 Buy
+15
New +$298 ﹤0.01% 3169
2022
Q3
Sell
-31
Closed -$1K 3282
2022
Q2
$1K Sell
31
-176
-85% -$3.93K ﹤0.01% 2980
2022
Q1
$5K Buy
+207
New +$5.37K ﹤0.01% 2497
2021
Q4
Sell
-16
Closed 3225
2021
Q3
$0 Sell
16
-6
-27% -$173 ﹤0.01% 3166
2021
Q2
$1K Sell
22
-478
-96% -$15.2K ﹤0.01% 2796
2021
Q1
$18K Buy
+500
New +$17.4K ﹤0.01% 1610
2020
Q3
Sell
-39
Closed -$1K 2715
2020
Q2
$1K Hold
39
﹤0.01% 2353
2020
Q1
$1K Sell
39
-61
-61% -$1.6K ﹤0.01% 2164
2019
Q4
$2K Sell
100
-300
-75% -$6.72K ﹤0.01% 1907
2019
Q3
$7K Buy
+400
New +$6.61K ﹤0.01% 1536

Other funds holding PETS

SignatureFD's PETS Position: Q3 2023 in Review

SignatureFD sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 213 shares — an estimated $2.94K sold.

SignatureFD first reported a position in PETS in Q3 2019 and held it in 12 quarters. The position peaked at $18K in Q1 2021. 138 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • SignatureFD reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • SignatureFD sold 213 PetMed Express shares in Q3 2023, an estimated $2.94K.
  • SignatureFD first reported a position in PetMed Express in Q3 2019 and held it in 12 quarters.
  • SignatureFD's PetMed Express position peaked at $18K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on SignatureFD's 13F filing for Q3 2023, filed 3 Nov 2023.